PBMs are Preparing for the Next Phase of COVID-19: Treatment Availability
Pharmacy Benefit Managers (PBMs) continue to implement patient-friendly tools in pharmacy benefits that lower prescription drug costs and improve quality including negotiating discounts with drugstores to reduce copays and other out-of-pockets costs, negotiating price concessions from drug manufacturers, and promoting more affordable brand and generics drugs.
Drug manufacturers should be lauded for undertaking an unprecedented effort to find vaccines and treatments for COVID-19. Those treatments, once approved, must be made widely available and affordable for everyone, and just as importantly, medications for chronic illnesses must remain accessible for patients. PBMs’ proven track record keeping drug costs in check and providing patients access to treatments will be crucially important to achieving that objective.
As the economy re-emerges from this difficult time, Winston Churchill’s words are apt: “Now this is not the end. It is not even the beginning of the end. But it is, perhaps, the end of the beginning.” During this uncertain time and beyond, patients and plan sponsors can count on PBMs to use their expertise and their negotiating power to provide affordable access to prescription drugs.
For more information about how PBMs are #OnYourRxSide during this pandemic, please click here.
Show you care!
Pharmacy benefit managers (PBMs) are your advocates in the health care system, working to lower out-of-control prescription drug costs for patients across the country.